158 related articles for article (PubMed ID: 11004532)
21. A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid β peptide-mediated neuronal disorder.
Cai C; Dai X; Zhu Y; Lian M; Xiao F; Dong F; Zhang Q; Huang Y; Zheng Q
Appl Microbiol Biotechnol; 2016 Jan; 100(2):825-35. PubMed ID: 26496918
[TBL] [Abstract][Full Text] [Related]
22. Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease.
Boyd-Kimball D; Sultana R; Poon HF; Lynn BC; Casamenti F; Pepeu G; Klein JB; Butterfield DA
Neuroscience; 2005; 132(2):313-24. PubMed ID: 15802185
[TBL] [Abstract][Full Text] [Related]
23. Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme.
McDermott JR; Gibson AM
Neurochem Res; 1997 Jan; 22(1):49-56. PubMed ID: 9021762
[TBL] [Abstract][Full Text] [Related]
24. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
[TBL] [Abstract][Full Text] [Related]
25. Icariin inhibits beta-amyloid peptide segment 25-35 induced expression of beta-secretase in rat hippocampus.
Nie J; Luo Y; Huang XN; Gong QH; Wu Q; Shi JS
Eur J Pharmacol; 2010 Jan; 626(2-3):213-8. PubMed ID: 19782061
[TBL] [Abstract][Full Text] [Related]
26. The role of cytosolic phospholipase A2 α in amyloid precursor protein induction by amyloid beta1-42 : implication for neurodegeneration.
Sagy-Bross C; Kasianov K; Solomonov Y; Braiman A; Friedman A; Hadad N; Levy R
J Neurochem; 2015 Mar; 132(5):559-71. PubMed ID: 25533654
[TBL] [Abstract][Full Text] [Related]
27. Binding of human proteins to amyloid-β protofibrils.
Rahman MM; Zetterberg H; Lendel C; Härd T
ACS Chem Biol; 2015 Mar; 10(3):766-74. PubMed ID: 25469473
[TBL] [Abstract][Full Text] [Related]
28. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
[TBL] [Abstract][Full Text] [Related]
29. A specific structural interaction of Alzheimer's peptide A beta 1-42 with alpha 1-antichymotrypsin.
Janciauskiene S; Eriksson S; Wright HT
Nat Struct Biol; 1996 Aug; 3(8):668-71. PubMed ID: 8756322
[No Abstract] [Full Text] [Related]
30. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
31. Modeling the binding mechanism of Alzheimer's Aβ1-42 to nicotinic acetylcholine receptors based on similarity with snake α-neurotoxins.
Maatuk N; Samson AO
Neurotoxicology; 2013 Jan; 34():236-42. PubMed ID: 23022323
[TBL] [Abstract][Full Text] [Related]
32. Identification of a chymotrypsin-like mast cell protease in rat brain capable of generating the N-terminus of the Alzheimer amyloid beta-protein.
Nelson RB; Siman R; Iqbal MA; Potter H
J Neurochem; 1993 Aug; 61(2):567-77. PubMed ID: 8336143
[TBL] [Abstract][Full Text] [Related]
33. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
34. Alpha1-antichymotrypsin/Alzheimer's peptide Abeta(1-42) complex perturbs lipid metabolism and activates transcription factors PPARgamma and NFkappaB in human neuroblastoma (Kelly) cells.
Sun YX; Wright HT; Janciauskiene S
J Neurosci Res; 2002 Feb; 67(4):511-22. PubMed ID: 11835318
[TBL] [Abstract][Full Text] [Related]
35. The role of macrophage migration inhibitory factor in Alzheimer's disease.
Bacher M; Deuster O; Aljabari B; Egensperger R; Neff F; Jessen F; Popp J; Noelker C; Reese JP; Al-Abed Y; Dodel R
Mol Med; 2010 Mar; 16(3-4):116-21. PubMed ID: 20200619
[TBL] [Abstract][Full Text] [Related]
36. Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide.
Yan SD; Roher A; Chaney M; Zlokovic B; Schmidt AM; Stern D
Biochim Biophys Acta; 2000 Jul; 1502(1):145-57. PubMed ID: 10899440
[TBL] [Abstract][Full Text] [Related]
37. In vitro amyloid-β binding and inhibition of amyloid-β self-association by therapeutic albumin.
Milojevic J; Costa M; Ortiz AM; Jorquera JI; Melacini G
J Alzheimers Dis; 2014; 38(4):753-65. PubMed ID: 24072068
[TBL] [Abstract][Full Text] [Related]
38. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
[TBL] [Abstract][Full Text] [Related]
39. Identification of N-terminally truncated pyroglutamate amyloid-β in cholesterol-enriched diet-fed rabbit and AD brain.
Perez-Garmendia R; Hernandez-Zimbron LF; Morales MA; Luna-Muñoz J; Mena R; Nava-Catorce M; Acero G; Vasilevko V; Viramontes-Pintos A; Cribbs DH; Gevorkian G
J Alzheimers Dis; 2014; 39(2):441-55. PubMed ID: 24240639
[TBL] [Abstract][Full Text] [Related]
40. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.
Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE
J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]